We are live on ! Find out more

1,762 hedge funds and large institutions have $119B invested in Merck in 2016 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 713 increasing their positions, 710 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 59

30% more funds holding in top 10

Funds holding in top 10: 106138 (+32)

11% more capital invested

Capital invested by funds: $107B → $119B (+$11.6B)

1% more funds holding

Funds holding: 1,7451,762 (+17)

0% more repeat investments, than reductions

Existing positions increased: 713 | Existing positions reduced: 710

0.6% less ownership

Funds ownership: 78.67%78.07% (-0.6%)

14% less call options, than puts

Call options by funds: $1.02B | Put options by funds: $1.18B

Holders
1,762
Holders Change
+17
Holders Change %
+0.97%
% of All Funds
47%
Holding in Top 10
138
Holding in Top 10 Change
+32
Holding in Top 10 Change %
+30.19%
% of All Funds
3.68%
New
92
Increased
713
Reduced
710
Closed
59
Calls
$1.02B
Puts
$1.18B
Net Calls
-$163M
Net Calls Change
-$87M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
1351
Cornerstone Capital
California
$588K +$44.7K +839 +9%
AIA
1352
Allegis Investment Advisors
Idaho
$584K -$87K -1,634 -13%
BFPW
1353
BOK Financial Private Wealth
Colorado
$581K +$562K +10,568 New
BSB
1354
Bangor Savings Bank
Maine
$580K +$66.3K +1,246 +13%
SCM
1355
Stonebridge Capital Management
California
$574K
AI
1356
Accredited Investors
Minnesota
$570K +$57.3K +1,076 +11%
OA
1357
Oxbow Advisors
Texas
$569K -$16.8K -315 -3%
SPC
1358
Stewart & Patten Company
California
$565K -$46.9K -881 -8%
RMSCM
1359
R.M. Sincerbeaux Capital Management
New York
$564K
NFG
1360
Nadler Financial Group
Illinois
$562K +$373 +7 +0.1%
SCP
1361
Sandhill Capital Partners
New York
$562K +$5.64K +106 +1%
WOC
1362
West Oak Capital
California
$560K +$43.1K +810 +9%
Kayne Anderson Rudnick Investment Management
1363
Kayne Anderson Rudnick Investment Management
California
$556K
VST
1364
Van Strum & Towne
California
$556K
CIC
1365
Chilton Investment Company
Connecticut
$554K
LOAMS
1366
Lombard Odier Asset Management (Switzerland)
Switzerland
$554K
WP
1367
WMS Partners
Maryland
$549K +$35.4K +665 +7%
CA
1368
Capital Advantage
California
$548K +$531K +9,972 New
TCM
1369
Traynor Capital Management
Pennsylvania
$528K -$30.2K -567 -6%
MWM
1370
Modera Wealth Management
New Jersey
$527K -$42.8K -805 -8%
PBO
1371
Peoples Bank (Ohio)
Ohio
$527K -$30.7K -577 -6%
LGC
1372
Laurel Grove Capital
California
$526K
EWM
1373
Endurance Wealth Management
Rhode Island
$524K -$9.69K -182 -2%
JWBC
1374
J.W. Burns & Co
New York
$523K -$5.59K -105 -1%
RHJA
1375
Rice Hall James & Associates
California
$519K

MRK Hedge Fund Activity: Q2 2016 in Review

1,762 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2016, worth a combined $119B — up 11% from $107B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new MRK positions and 59 closed out — a net gain of 33 holders — while 713 added to existing stakes and 710 trimmed.

The largest buyer was Macquarie Group, adding an estimated $718M. The largest seller was Royal London Asset Management, cutting an estimated $1.98B.

  • 1,762 institutional investors held Merck (MRK) as of Q2 2016, up from 1,745 in Q1 2016.
  • Funds reported $119B of Merck stock for Q2 2016, up 11% quarter-over-quarter.
  • 92 funds opened new Merck positions in Q2 2016 and 59 closed out, a net change of +33 holders.
  • The largest Merck buyer in Q2 2016 was Macquarie Group, an estimated $718M added.
  • The largest Merck seller in Q2 2016 was Royal London Asset Management, an estimated $1.98B sold.

Based on aggregated 13F filings for Q2 2016.